OLAnzaPiNE

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

OLAnzaPiNE

Oct 2, 2024, 14:53 | Blog

Eric Singhi: An opportunity to improve patient education

Eric Singhi shared a post on X: "I'm a big advocate for olanzapine and its…

Aug 14, 2024, 07:33 | Insight

Olanzapine as antiemetic prophylaxis in chemotherapy

Elisa Agostinetto shared on X: "Olanzapine as antiemetic prophylaxis in chemotherapy. In this randomized phase…

Aug 12, 2024, 06:05 | Insight

Results suggest olanzapine should be a standard to reduce chemotherapy-induced nausea and vomiting

Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust shared a post on…

Jul 21, 2024, 21:49 | Blog

Mark Lewis: Consider Olanzapine for chemotherapy-induced nausea/vomiting

Mark Lewis posted on X/Twitter about a recent paper by Jyoti Bajpai et al., commenting: "I…

Dec 16, 2023, 18:18 | Insight

SABCS23 Day 2 Highlights by Oncology Brothers

Oncology Brothers have recently shared their highlights from SABCS23. Below we feature the second day's…

All: 5 Posts: 1 - 100

ASCO GI 2025 - Everything You Need To Know About Biggest Gastrointestinal cancer Symposium

Side Effects of Radiotherapy: Risks and What to Know

Isabel Rubio has been elected as the President of the European Cancer Organisation for 2026-2027

Dr. Richard Pazdur's 25 Year WAR on Cancer at the FDA!

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023